Supernus Pharmaceuticals Inc logo

Supernus Pharmaceuticals Inc

NEW
FRA:S49 (USA)  
€ 42.4 -1.6 (-3.64%) Jul 10
At Loss
P/B:
2.53
Market Cap:
€ 2.47B ($ 2.82B)
Enterprise V:
€ 2.17B ($ 2.48B)
Volume:
0
Avg Vol (2M):
115.00
Trade In:

Supernus Pharmaceuticals Inc (FRA:S49) Dividend

Supernus Pharmaceuticals Inc (FRA:S49) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -1.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:S49 Dividend

Does Supernus Pharmaceuticals Inc (FRA:S49) pay a dividend?

Supernus Pharmaceuticals Inc (FRA:S49) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Supernus Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Supernus Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -1.9% over the past 3 years.

What are dividend-paying alternatives to Supernus Pharmaceuticals Inc?

For dividend-paying alternatives in Supernus Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.